CH Biotech R&D Dividends and Buybacks
Dividend criteria checks 1/6
CH Biotech R&D is a dividend paying company with a current yield of 4.33%.
Key information
4.3%
Dividend yield
-0.0008%
Buyback Yield
Total Shareholder Yield | 4.3% |
Future Dividend Yield | n/a |
Dividend Growth | 18.6% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | NT$3.590 |
Payout ratio | 96% |
Recent dividend and buyback updates
Recent updates
CH Biotech R&D (GTSM:6534) Takes On Some Risk With Its Use Of Debt
Apr 05A Look At CH Biotech R&D's (GTSM:6534) Share Price Returns
Mar 18Are CH Biotech R&D Co., Ltd.'s (GTSM:6534) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Feb 09Returns On Capital At CH Biotech R&D (GTSM:6534) Paint An Interesting Picture
Jan 11Does CH Biotech R&D (GTSM:6534) Have A Healthy Balance Sheet?
Dec 15Tread With Caution Around CH Biotech R&D Co., Ltd.'s (GTSM:6534) 1.8% Dividend Yield
Nov 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 6534 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 6534's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
CH Biotech R&D Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (6534) | 4.3% |
Market Bottom 25% (TW) | 1.7% |
Market Top 25% (TW) | 4.4% |
Industry Average (Chemicals) | 2.7% |
Analyst forecast (6534) (up to 3 years) | n/a |
Notable Dividend: 6534's dividend (4.33%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).
High Dividend: 6534's dividend (4.33%) is low compared to the top 25% of dividend payers in the TW market (4.42%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (95.6%), 6534's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 6534 is paying a dividend but the company has no free cash flows.